Identification of a new murine tumor necrosis factor receptor locus that contains two novel murine receptors for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)
about
Clinical perspectives of TRAIL: insights into central nervous system disordersHistorical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journeyGetting TRAIL back on track for cancer therapyFollowing a TRAIL: update on a ligand and its five receptorsProtective effects of neurotrophic factors on tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis of murine adrenal chromaffin cell line tsAM5D.β-Adrenergic receptor-mediated transactivation of epidermal growth factor receptor decreases cardiomyocyte apoptosis through differential subcellular activation of ERK1/2 and Akt.Blocking TRAIL-DR5 signaling with soluble DR5 alleviates acute kidney injury in a severely burned mouse model.Inhibition of the TRAIL death receptor by CMV reveals its importance in NK cell-mediated antiviral defense.Advances in Viral Vector-Based TRAIL Gene Therapy for Cancer.Interactions of tumor necrosis factor (TNF) and TNF receptor family members in the mouse and human.Targeted expression of tumor necrosis factor-related apoptosis-inducing ligand TRAIL in skin protects mice against chemical carcinogenesis.Whole Genome Sequence of Multiple Myeloma-Prone C57BL/KaLwRij Mouse Strain Suggests the Origin of Disease Involves Multiple Cell Types.Dendritic Cells Cause Bone Lesions in a New Mouse Model of HistiocytosisTRAIL and its receptors as targets for cancer therapy.TRAIL-R deficiency in mice enhances lymph node metastasis without affecting primary tumor developmentTNF-related apoptosis-inducing ligand (TRAIL) exerts therapeutic efficacy for the treatment of pneumococcal pneumonia in mice.TRAIL: not just for tumors anymore?Induction of tumor-specific T cell immunity by anti-DR5 antibody therapy.Combination therapy of established cancer using a histone deacetylase inhibitor and a TRAIL receptor agonist.Overcoming resistance to TRAIL-induced apoptosis in solid tumor cells by simultaneously targeting death receptors, c-FLIP and IAPs.Resistance to TRAIL in non-transformed cells is due to multiple redundant pathways.The promise of cancer therapeutics targeting the TNF-related apoptosis-inducing ligand and TRAIL receptor pathway.IAP antagonists sensitize murine osteosarcoma cells to killing by TNFαTRAIL-deficient mice exhibit delayed regression of retinal neovascularization.Following TRAIL's path in the immune system.Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) signaling and cell death in the immature central nervous system after hypoxia-ischemia and inflammation.Hetero-oligomerization between the TNF receptor superfamily members CD40, Fas and TRAILR2 modulate CD40 signallingMolecular mechanisms of neonatal brain injury.Resistance to TRAIL and how to surmount it.Regulation of TRAIL-receptor expression by the ubiquitin-proteasome system.Distinct roles of TNF-related apoptosis-inducing ligand (TRAIL) in viral and bacterial infections: from pathogenesis to pathogen clearance.Preventing Overheating: Tight Control of Gut Innate Immunity in Health and Disease.Decoy receptors block TRAIL sensitivity at a supracellular level: the role of stromal cells in controlling tumour TRAIL sensitivity.The role of selected flavonols in tumor necrosis factor-related apoptosis-inducing ligand receptor-1 (TRAIL-R1) expression on activated RAW 264.7 macrophages.Chrysin, apigenin and acacetin inhibit tumor necrosis factor-related apoptosis-inducing ligand receptor-1 (TRAIL-R1) on activated RAW264.7 macrophages.Functional roles of tumor necrosis factor-related apoptosis-inducing ligand-DR5 interaction in B16F10 cells by activating the nuclear factor-κB pathway to induce metastatic potential.Regulatory functions of TRAIL in hematopoietic progenitors: human umbilical cord blood and murine bone marrow transplantation.Development of a radioiodinated apoptosis-inducing ligand, rhTRAIL, and a radiolabelled agonist TRAIL receptor antibody for clinical imaging studiesTRAIL-R deficiency in mice promotes susceptibility to chronic inflammation and tumorigenesis.Critical roles of TRAIL in hepatic cell death and hepatic inflammation.
P2860
26f06c6897bce447a704525126b5334b9734892333af62243b2dac3922ee090bc332447ce629f30a486d323d043633fd4ab2f40c2aed2f5dfd961683630401c97d48b2c559dd2044ee68873b33df18d78cd27b043c9be27695adef98f823de0bdfe6bde792deea18846db2568ad4fb8ae4973e969f6b141fbea4a426240b775273a4d3b0efad3560c56cdda0c868595317be99886995f14dc62427389b597503
P248
Q26766570-6B4CC110-515A-4378-B724-46C590FAC013Q26991848-75A493DD-4199-46E8-9C5C-2DED6F1319CDQ27027460-A56B53E5-1741-4536-9411-504CEDB5AC8DQ28292767-F80AC4B9-AF4F-45F4-A546-64353C3C4992Q33246715-14539B15-6896-45B7-8E99-C80DC632607BQ33680497-B037B58C-AB19-4FD3-AA24-D3195E998C27Q33898510-93F31969-F30B-493F-AE3D-3D03B3C17AF9Q34047484-8D861F16-9B1D-4FDD-8D75-ECB44A697EDBQ34384021-1FFB8B9F-EFE2-4346-8A93-6EA5D4A91D04Q34503355-33A841AC-4B8F-4A88-B8DE-73D05A106C0FQ34809370-92BAB25E-056D-43C5-9FF2-91C31D07197CQ35644558-299A14AD-6667-4B8A-9CCC-CD27EE03B5A1Q35738586-A4D7B978-236C-41B6-AFB2-465EA111F9E4Q35927476-752C21E5-92F3-429B-9CBD-5F11E87489F7Q36249542-10ABF3E4-F37C-4C11-9BF2-0A37C64AEE81Q36340830-E63F1CD4-E5DF-443B-8EBD-2DB2D878F736Q36340862-8C6AF6EA-7489-4FD6-AA52-CDC968EF3D79Q36399234-19806C6A-D620-4843-99C0-102D08DF4CBCQ36837553-E86784B1-7D53-460A-B8A4-C88D0D4EE264Q36992161-24257453-CB13-4D5A-9038-9759D6F194D7Q37061991-2F2E88F2-D75A-4BAB-9F60-6984E4D92430Q37302737-E0D7FC90-0AC9-48BA-9481-B90D5727A233Q37376164-149BF361-983F-4AD0-8927-1D5D55E31D1CQ37462599-D599D85C-F0CC-462B-A32B-F15B98EB091DQ37498946-48E59E54-477D-4E8F-9C63-7684FBE69AB4Q37691639-E81A59EF-DF17-49E9-A9FC-3CD1BAD37929Q37745184-6415161E-5A4D-48A7-BA1A-CE4C4720B61AQ37987945-81342347-B58E-42BA-A42F-EBD077125DCDQ37992546-E96009E3-F8F6-4CBD-9C5E-664062C2A7C8Q38260461-7D7FB03E-97E0-4C2A-BCF5-05F8219FC5E3Q38760809-4F64ECB3-B961-4944-87B1-96AA93492B3DQ38857818-177FB697-8B44-42AC-9525-43ABC2CAE729Q38866710-32D9D907-04AF-43CB-949E-A161142ABCA5Q38920840-8D26A9D0-453C-48D3-BF9D-911EB9AA7174Q38979660-6153AC07-A019-4BB9-9728-2312C989B006Q39205404-D6D4DF3A-3071-47BD-BDA6-4C85B59E0770Q39256130-123BC59C-088F-4C84-933C-CCA5AF1DD971Q39455419-6C7B3FC9-CF15-4BCD-9CD7-FBDD91494453Q40035477-7334B0A5-0EB4-4892-B2B3-08FC6349C9A8Q40364687-6DD13B99-77FF-43B4-82DC-8D3223B79CCB
P2860
Identification of a new murine tumor necrosis factor receptor locus that contains two novel murine receptors for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)
description
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique Journal of Biological Chemistry
@fr
artículu científicu espublizáu en 2003
@ast
im Februar 2003 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2003/02/14)
@sk
vědecký článek publikovaný v roce 2003
@cs
wetenschappelijk artikel (gepubliceerd op 2003/02/14)
@nl
наукова стаття, опублікована в лютому 2003
@uk
name
Identification of a new murine ...... ptosis-inducing ligand (TRAIL)
@ast
Identification of a new murine ...... ptosis-inducing ligand (TRAIL)
@en
Identification of a new murine ...... ptosis-inducing ligand (TRAIL)
@nl
type
label
Identification of a new murine ...... ptosis-inducing ligand (TRAIL)
@ast
Identification of a new murine ...... ptosis-inducing ligand (TRAIL)
@en
Identification of a new murine ...... ptosis-inducing ligand (TRAIL)
@nl
prefLabel
Identification of a new murine ...... ptosis-inducing ligand (TRAIL)
@ast
Identification of a new murine ...... ptosis-inducing ligand (TRAIL)
@en
Identification of a new murine ...... ptosis-inducing ligand (TRAIL)
@nl
P2093
P2860
P921
P3181
P356
P1476
Identification of a new murine ...... ptosis-inducing ligand (TRAIL)
@en
P2093
Alexey Lugovskoy
Aubry Tardivel
Beth Browning
DaHai Gong
Dian Olson
Herman Van Vlijmen
Kay Hofmann
Linda C. Burkly
Max Dobles
Sylvie Hertig
P2860
P304
P3181
P356
10.1074/JBC.M210783200
P407
P577
2003-02-14T00:00:00Z